Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric Devroe currently holds 186,728 shares of Acrivon Therapeutics, Inc. (ACRV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Devroe has been a net buyer of ACRV stock. They have purchased $17.2K and sold $0 worth of shares.
Eric Devroe's most recent insider trade was on Mar 1, 2026, when they sold 186,728 shares at $0.00 per share.
Eric Devroe serves as Executive at Acrivon Therapeutics, Inc. (ACRV). They have executed 13 insider transactions totaling $17.2K over their tenure at the company.
Eric Devroe holds the position of Executive at Acrivon Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Eric Devroe has shown a buying trading pattern, with $17.2K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Eric Devroe was on Jan 13, 2026, when they purchased $17.2K worth of ACRV shares. This transaction involved 10,000 shares at $1.72 per share.
Eric Devroe currently owns 186,728 shares of Acrivon Therapeutics, Inc. (ACRV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric Devroe's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric Devroe has 13 Form 4 filings on record as an insider at Acrivon Therapeutics, Inc..
Set alerts for Eric Devroe and 40,000+ other insiders.